Cargando…

Protective effects of cerium oxide nanoparticles in non-alcoholic fatty liver disease (NAFLD) and carbon tetrachloride-induced liver damage in rats: Study on intestine and liver

BACKGROUND AND AIMS: Nanoparticles could represent a therapeutic approach for the treatment of various diseases. It has been reported that cerium oxide nanoparticles (CeO(2) NPs) have potential useful effects. Therefore, we aimed to examine the protective effects of the CeO(2) NPs in two models of l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abbasi, Ebrahim, Vafaei, Seyed Alireza, Naseri, Nima, Darini, Ali, Azandaryani, Masoumeh Taheri, Ara, Farhad Kian, Mirzaei, Fatemeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Articles from the NAFLD: from Molecular Basis to Therapeutic Advances Special Issue
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626579/ https://www.ncbi.nlm.nih.gov/pubmed/34870139 http://dx.doi.org/10.1016/j.metop.2021.100151

Ejemplares similares

Favorable effects of Anethum graveolens on liver oxidative stress and cholesterol 7 alpha-hydroxylase levels in non-alcoholic fatty liver disease (NAFLD) rat models
por: Abbasi, Ebrahim, et al.
Publicado: (2021)

Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)
por: Zarghamravanbakhsh, Paria, et al.
Publicado: (2021)

Noninvasive assessment of fibrosis among patients with nonalcoholic fatty liver disease [NAFLD]
por: Bernstein, David, et al.
Publicado: (2022)

The role of zinc in the prevention and treatment of nonalcoholic fatty liver disease
por: Barbara, Mary, et al.
Publicado: (2021)

Prevalence of elevated liver enzymes and its relationship with type 2 diabetes mellitus in North Indian adults
por: Alam, Sana, et al.
Publicado: (2021)

Editorial: Special issue: Non-alcoholic fatty liver disease: From molecular basis to therapeutic advances
por: Nasiri-Ansari, Narjes, et al.
Publicado: (2023)

Effect of 8 Weeks milk thistle powder (silymarin extract) supplementation on fatty liver disease in patients candidates for bariatric surgery
por: Mirhashemi, Seyed Hadi, et al.
Publicado: (2022)

Emerging roles for stress kinase p38 and stress hormone fibroblast growth factor 21 in NAFLD development
por: Liu, Junli, et al.
Publicado: (2021)

DRAK2-SRSF6-regulated RNA alternative splicing is a promising therapeutic target in NAFLD/NASH
por: Dalamaga, Maria, et al.
Publicado: (2021)

Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease
por: Shen, Feng, et al.
Publicado: (2015)

COVID-19 vaccines: Current evidence and considerations
por: Tavilani, Alireza, et al.
Publicado: (2021)

Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease
por: Schwimmer, J B, et al.
Publicado: (2013)

Deficiency of SREBP1c modulates autophagy mediated lipid droplet catabolism during oleic acid induced steatosis
por: Sozen, Erdi, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention
por: Tacke, Frank, et al.
Publicado: (2021)

Modelling NAFLD disease burden in four Asian regions—2019‐2030
por: Estes, Chris, et al.
Publicado: (2020)

Causes of erectile dysfunction in non-alcoholic fatty liver disease
por: Tarik Kani, Haluk, et al.
Publicado: (2021)

Abscess of the Liver
por: Roy, Gopaul Chunder
Publicado: (1868)

Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference
por: Munteanu, M., et al.
Publicado: (2016)

Hydatid Disease of the Liver
por: Browne, J.
Publicado: (1869)

Abscess of Liver Bursting into the Pericardium
por: Dymock, William
Publicado: (1866)

Abscess of the Liver Successfully Treated by Tapping
por: Bowser, H. C.
Publicado: (1867)

Differential effects of olive oil, soybean oil, corn oil and lard oil on carbon tetrachloride-induced liver fibrosis in mice
por: Gao, Yanan, et al.
Publicado: (2019)

Beneficial effects of Chinese herbs in the treatment of fatty liver diseases
por: Panyod, Suraphan, et al.
Publicado: (2020)

The risk of liver cancer in autoimmune liver diseases
por: Lleo, Ana, et al.
Publicado: (2019)

Action of Mercury on the Liver
Publicado: (1873)

Primary Cancer of the Liver; Secondary Deposit in the Intestines and Pleuræ
por: Porter, A.
Publicado: (1869)

Variation in Bile Microbiome by the Etiology of Cholestatic Liver Disease
por: Tyc, Olaf, et al.
Publicado: (2020)

Exosomes as therapeutic vehicles in liver diseases
por: Ding, Jingyi, et al.
Publicado: (2021)

Racial and ethnic differences in diet quality and food insecurity among adults with fatty liver and significant fibrosis: a U.S. population‐based study
por: Kardashian, Ani, et al.
Publicado: (2022)

Liver Function Tests and Carbon Tetrachloride
por: Bose, J. P., et al.
Publicado: (1924)

The role of bile acids in cholestatic liver injury
por: Cai, Shi-Ying, et al.
Publicado: (2021)

Liver failure—future challenges and remaining questions
por: Lemmer, Peter, et al.
Publicado: (2021)

Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non‐alcoholic fatty liver disease; the importance of an elevated mean platelet volume
por: Abeles, Robin D., et al.
Publicado: (2019)

An Algorithmic Approach to NAFLD Screening: From PCP to Specialist
por: Trivedi, Hirsh D.
Publicado: (2020)

A Case of Worms, Distoma Hepaticum, or Liver Fluke, in the Human Intestines
por: Ghose, Beny Madub
Publicado: (1869)

Case of Ruptured Liver, Spleen, and Kidney, with Fracture of One Arm, &c., &c.
por: Roy, Gopal Chunder
Publicado: (1867)

Interview with American Association for the Study of Liver Diseases president Dr. Anna Lok
por: Lok, Anna S.F.
Publicado: (2017)

Effect of dill tablet (Anethum graveolens L) on antioxidant status and biochemical factors on carbon tetrachloride-induced liver damage on rat
por: Oshaghi, Ebrahim Abbasi, et al.
Publicado: (2016)

The synergistic effect of Citrus bergamia and Cynara cardunculus extracts on vascular inflammation and oxidative stress in non-alcoholic fatty liver disease
por: Musolino, Vincenzo, et al.
Publicado: (2020)

Non-alcoholic fatty liver diseases: current challenges and future directions
por: Roeb, Elke
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_avksnua90bpa5m832v06vf78r1